Inhibitors of y-herpesvirus replication and their mode of action KU Leuven
Since the discovery of Epstein-Barr virus (EBV) and Kaposis sarcoma-associated herpesvirus (KSHV), 50 and 20 years ago, respectively, little progress has been made towards therapies directed against these oncogenic viruses. A primary infection with EBV may be associated with infectious mononucleosis when it occurs in adolescence or early adulthood. The severity in symptoms related to infectious mononucleosis varies greatly between individuals ...